In 2017 is there life left in hobbyist retailers?
The sector's London-listed players are being forced to diversify away from the traditional annuities market. Which companies are heading in the right direction?
The challenges faced by the UK speciality chemicals sector following our vote to leave the EU need to be set in context against the global structural drivers
Following Mylan's failure to launch an unbranded version of GSK's asthma drug, Advair, we take a look at the difficulties facing generic drugmakers
On balance, 2017 has started brightly for gold stocks. But this doesn't imply that the stage is set for another bull run